全文获取类型
收费全文 | 1756300篇 |
免费 | 133693篇 |
国内免费 | 8685篇 |
专业分类
耳鼻咽喉 | 22255篇 |
儿科学 | 56397篇 |
妇产科学 | 47247篇 |
基础医学 | 248455篇 |
口腔科学 | 50153篇 |
临床医学 | 159591篇 |
内科学 | 341594篇 |
皮肤病学 | 39396篇 |
神经病学 | 134263篇 |
特种医学 | 66395篇 |
外国民族医学 | 274篇 |
外科学 | 263404篇 |
综合类 | 51467篇 |
现状与发展 | 18篇 |
一般理论 | 542篇 |
预防医学 | 128374篇 |
眼科学 | 42035篇 |
药学 | 131352篇 |
85篇 | |
中国医学 | 8592篇 |
肿瘤学 | 106789篇 |
出版年
2021年 | 14965篇 |
2019年 | 16024篇 |
2018年 | 22615篇 |
2017年 | 17620篇 |
2016年 | 18879篇 |
2015年 | 22425篇 |
2014年 | 30417篇 |
2013年 | 41864篇 |
2012年 | 58598篇 |
2011年 | 61623篇 |
2010年 | 36783篇 |
2009年 | 33865篇 |
2008年 | 55729篇 |
2007年 | 58836篇 |
2006年 | 58930篇 |
2005年 | 56146篇 |
2004年 | 53287篇 |
2003年 | 50355篇 |
2002年 | 48331篇 |
2001年 | 93176篇 |
2000年 | 95021篇 |
1999年 | 78311篇 |
1998年 | 19937篇 |
1997年 | 17439篇 |
1996年 | 17347篇 |
1995年 | 17555篇 |
1994年 | 15982篇 |
1993年 | 14466篇 |
1992年 | 57769篇 |
1991年 | 55692篇 |
1990年 | 53306篇 |
1989年 | 51040篇 |
1988年 | 46351篇 |
1987年 | 45149篇 |
1986年 | 42357篇 |
1985年 | 40118篇 |
1984年 | 29399篇 |
1983年 | 24905篇 |
1982年 | 13885篇 |
1979年 | 25497篇 |
1978年 | 17542篇 |
1977年 | 14860篇 |
1976年 | 13838篇 |
1975年 | 14522篇 |
1974年 | 17613篇 |
1973年 | 16916篇 |
1972年 | 15673篇 |
1971年 | 14438篇 |
1970年 | 13427篇 |
1969年 | 12506篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
31.
Paul G. Richardson Fredrik Schjesvold Katja Weisel Philippe Moreau Larry D. Anderson Darrell White Paula Rodriguez-Otero Pieter Sonneveld Monika Engelhardt Matthew Jenner Alessandro Corso Jan Dürig Michel Pavic Morten Salomo Meral Beksac Albert Oriol Jindriska Lindsay Anna Marina Liberati Monica Galli Pawel Robak Alessandra Larocca Munci Yagci Filiz Vural Abraham S. Kanate Ruiyun Jiang Lara Grote Teresa Peluso Meletios Dimopoulos 《European journal of haematology》2022,108(1):73-83
32.
33.
Dong Yang Ronggang Yang Jiangyi Shen Lu Huang Shuai Men Tiancai Wang 《Journal of applied toxicology : JAT》2022,42(4):683-693
Sinensetin is a polymethoxylated flavone with anti-inflammatory and anti-oxidative activities. This work aimed to explore the function and mechanism of sinensetin in oxygen and glucose deprivation/reperfusion (OGD/R)-induced neurotoxicity. The overlapping target genes of cerebral stroke and sinensetin were determined according to GeneCards and ParmMapper tools and were subjected to Gene Ontology (GO) annotations and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Human cerebral microvascular endothelial cells (HCMECs) were stimulated with OGD/R. Neurotoxicity was investigated by Cell Counting Kit-8, lactate dehydrogenase (LDH) release, reactive oxygen species (ROS) level, qRT-PCR, and TUNEL analysis. The proteins (p38, JNK, and ERK) in mitogen-activated protein kinase (MAPK) signaling were measured using Western blotting. Total of 50 overlapping target genes of cerebral stroke and sinensetin were predicted. Pathway analysis showed they might be involved in the MAPK pathway. Sinensetin attenuated OGD/R-induced neurotoxicity by mitigating viability reduction, LDH release, ROS generation, inflammatory response, and apoptosis in HCMECs. Sinensetin weakened OGD/R-induced activation of the MAPK pathway via decreasing the phosphorylation of p38, JNK, and ERK. The pathway inhibitors mitigated the activation of the MAPK signaling, and sinensetin exacerbated this effect. The inhibitors reversed OGD/R-induced neurotoxicity in HCMECs, and sinensetin contributed to this role. Overall, sinensetin prevents OGD/R-induced neurotoxicity through decreasing the activation of MAPK pathway. 相似文献
34.
35.
Die Anaesthesiologie - Als Meralgia paraesthetica (MP) bezeichnet man eine zu den neurologischen Engpasssyndromen zählende Schädigung des aus dem Plexus lumbalis entspringenden sensiblen... 相似文献
36.
Delirium is one of the most commonly occurring postoperative complications in older adults. It occurs due to the vulnerability of cerebral functioning to pathophysiological stressors. Identification of those at increased risk of developing delirium early in the surgical pathway provides an opportunity for modification of predisposing and precipitating risk factors and effective shared decision-making. No single delirium prediction tool is used widely in surgical settings. Multi-component interventions to prevent delirium involve structured risk factor modification supported by geriatrician input; these are clinically efficacious and cost effective. Barriers to the widespread implementation of such complex interventions exist, resulting in an ‘implementation gap’. There is a lack of evidence for pharmacological prophylaxis for the prevention of delirium. Current evidence suggests that avoidance of peri-operative benzodiazepines, careful titration of anaesthetic depth guided by processed electroencephalogram monitoring and treatment of pain are the most effective strategies to minimise the risk of delirium. Addressing postoperative delirium requires a collaborative, whole pathway approach, beginning with the early identification of those patients who are at risk. The research agenda should continue to examine the potential for pharmacological prophylaxis to prevent delirium while also addressing how successful models of delirium prevention can be translated from one setting to another, underpinned by implementation science methodology. 相似文献
37.
38.
Karl Johnson Katherine W. Saylor Isabella Guynn Karen Hicklin Jonathan S. Berg Kristen Hassmiller Lich 《Genetics in medicine》2022,24(2):262-288
PurposeUnderstanding the value of genetic screening and testing for monogenic disorders requires high-quality, methodologically robust economic evaluations. This systematic review sought to assess the methodological quality among such studies and examined opportunities for improvement.MethodsWe searched PubMed, Cochrane, Embase, and Web of Science for economic evaluations of genetic screening/testing (2013-2019). Methodological rigor and adherence to best practices were systematically assessed using the British Medical Journal checklist.ResultsAcross the 47 identified studies, there were substantial variations in modeling approaches, reporting detail, and sophistication. Models ranged from simple decision trees to individual-level microsimulations that compared between 2 and >20 alternative interventions. Many studies failed to report sufficient detail to enable replication or did not justify modeling assumptions, especially for costing methods and utility values. Meta-analyses, systematic reviews, or calibration were rarely used to derive parameter estimates. Nearly all studies conducted some sensitivity analysis, and more sophisticated studies implemented probabilistic sensitivity/uncertainty analysis, threshold analysis, and value of information analysis.ConclusionWe describe a heterogeneous body of work and present recommendations and exemplar studies across the methodological domains of (1) perspective, scope, and parameter selection; (2) use of uncertainty/sensitivity analyses; and (3) reporting transparency for improvement in the economic evaluation of genetic screening/testing. 相似文献
39.
40.
目的探讨维持性血液透析(MHD)患者血清维生素D水平对下肢肌力减退的预测作用。 方法横断面研究设计,选择2018年9月至10月于战略支援部队特色医学中心血液净化中心的95例MHD患者,检测其血清25-羟维生素D3[25(OH)D3]水平,采用5次站立-坐下实验(5-STS)评价其下肢肌力。根据5-STS完成时间将MHD患者分为下肢肌力正常组(n=85)与减退组(n=10),比较两组患者人口学特征、实验室指标。采用多因素Logistic回归分析下肢肌力减退的影响因素,绘制受试者工作特征(ROC)曲线分析上述因素预测MHD患者发生下肢肌力减退的特异度和敏感度。 结果95例MHD患者血清25(OH)D3水平为11.00~99.50 nmol/L,中位数31.23(19.90~43.30)nmol/L;5-STS完成时间为3.55 s~18.71 s,中位数9.81(7.12,12.43)s,下肢肌力减退者10例(10.53%)。多因素Logistic回归分析显示,血清25(OH)D3是MHD患者下肢肌力减退的保护性因素[OR=0.761,95%CI(0.592~0.978),P=0.033]。进一步ROC曲线分析显示,25(OH)D3对应的ROC曲线下面积为0.815,其预测MHD患者发生下肢肌力减退的敏感度为80.00%,特异度为80.00%。 结论MHD患者血清25(OH)D3水平普遍较低,下肢肌力减退者更为明显;血清维生素D水平对MHD患者是否存在下肢肌力减退具有较好的预测价值。 相似文献